RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Clinical trials for RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could an arthritis drug shrink Children's brain tumors?
Disease control Recruiting nowThis study tests a drug called tocilizumab, normally used for arthritis, in children and young adults with a rare brain tumor called adamantinomatous craniopharyngioma that has come back or is growing. The goal is to see if the drug can shrink the tumor or stop it from getting wo…
Matched conditions: RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
New hope for kids with rare brain tumor: targeted pill shows promise
Disease control Recruiting nowThis study tests an oral drug called MEKTOVI (binimetinib) in children and young adults (ages 1 to 39) with a rare brain tumor called adamantinomatous craniopharyngioma that has come back or grown after treatment. The drug works by blocking certain signals that help tumors grow. …
Matched conditions: RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 05:05 UTC